Q1 2024 EPS Estimates for Corcept Therapeutics Incorporated (NASDAQ:CORT) Lifted by Zacks Research
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Stock analysts at Zacks Research upped their Q1 2024 earnings per share (EPS) estimates for Corcept Therapeutics in a research note issued on Tuesday, December 26th. Zacks Research analyst K. Das now anticipates that the biotechnology company will post earnings per share of $0.20 for the quarter, […]
More Stories
ProShare Advisors LLC Has $358,000 Holdings in United States Steel Co. (NYSE:X)
ProShare Advisors LLC cut its holdings in United States Steel Co. (NYSE:X – Free Report) by 46.0% during the 4th...
Quantinno Capital Management LP Takes $79,000 Position in NextDecade Co. (NASDAQ:NEXT)
Quantinno Capital Management LP bought a new stake in NextDecade Co. (NASDAQ:NEXT – Free Report) during the fourth quarter, according...
Pitney Bowes Inc. (NYSE:PBI) Holdings Increased by ProShare Advisors LLC
ProShare Advisors LLC lifted its stake in Pitney Bowes Inc. (NYSE:PBI – Free Report) by 46.1% in the fourth quarter,...
10,012 Shares in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Purchased by Quantinno Capital Management LP
Quantinno Capital Management LP bought a new position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) during the fourth quarter,...
Man Group plc Acquires New Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Man Group plc acquired a new stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) in the 4th quarter,...
ProShare Advisors LLC Purchases 434 Shares of KBR, Inc. (NYSE:KBR)
ProShare Advisors LLC lifted its position in KBR, Inc. (NYSE:KBR – Free Report) by 7.5% in the fourth quarter, according...